semaglutide tablets patent expiry India's Dr Reddy's plans to launch generic obesity drugs in 87 countries next year, CEO says Brazilian federal court denies semaglutide
Description
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study
In December 2022, semaglutide was also indicated for chronic weight management in pediatric patients aged 12 years and older
GLP-1 receptor agonists may be considered for their FDA-approved indications glycemic control in type 2 diabetes or chronic weight management in obesitybut should not be viewed as treatments for Hashimoto's disease itself
The Lancet, 402(10401), 529544
Does Tirzepatide Get into Breast Milk
